Experimental cell treatment for ankle cartilage halted early
NCT ID NCT02537067
First seen Apr 22, 2026 · Last updated Jun 17, 2026 · Updated 13 times
Summary
This study tested a treatment called Chondron, which uses a person's own cartilage cells to repair damaged ankle cartilage. The trial aimed to see if the treatment could improve cartilage grade and foot/ankle function over 18 months. It included 28 people aged 15 to 65 with moderate to severe cartilage defects. The study was terminated early, so results are limited.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for DEFECT OF ARTICULAR CARTILAGE are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Eulji General Hospital
Seoul, Seoul, South Korea
-
Myongji Hospital
Goyang-si, Gyeonggi-do, South Korea
Conditions
Explore the condition pages connected to this study.